메뉴 건너뛰기
Internal Medicine Journal
Volumn 38, Issue 8, 2008, Pages 635-637
Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid
Author keywords

Bisphosphonates; Diphosphonates; Hypocalcaemia; Multiple myeloma; Zoledronic acid
Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CREATININE; LOOP DIURETIC AGENT; MAGNESIUM; PARATHYROID HORMONE; THALIDOMIDE; VITAMIN D; ZOLEDRONIC ACID;
EID: 51349102194     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01580.x     Document Type: Article
Times cited : (54)
References (10)
  • 1
    • 0035863508 scopus 로고    scopus 로고
    • Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials
    • Major P, Lortholary A, Hon J et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001 19 : 558 67.
    • (2001) J Clin Oncol , vol.19 , pp. 558-67
    • Major, P.1    Lortholary, A.2    Hon, J.3
  • 2
    • 33646444443 scopus 로고    scopus 로고
    • Bisphosphonates for malignancy-related bone disease: Current status, future developments
    • Body JJ. Bisphosphonates for malignancy-related bone disease: current status, future developments. Support Care Cancer 2006 14 : 408 18.
    • (2006) Support Care Cancer , vol.14 , pp. 408-18
    • Body, J.J.1
  • 3
    • 33646863929 scopus 로고    scopus 로고
    • Management of the adverse effects associated with intravenous bisphosphonates
    • Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006 17 : 897 907.
    • (2006) Ann Oncol , vol.17 , pp. 897-907
    • Tanvetyanon, T.1    Stiff, P.J.2
  • 4
    • 29244451515 scopus 로고    scopus 로고
    • Symptomatic hypocalcemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma
    • Henley D, Kaye J, Walsh J, Cull G. Symptomatic hypocalcemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma. Intern Med J 2005 35 : 726 8.
    • (2005) Intern Med J , vol.35 , pp. 726-8
    • Henley, D.1    Kaye, J.2    Walsh, J.3    Cull, G.4
  • 5
    • 18744390817 scopus 로고    scopus 로고
    • Profound hypocalcaemia after zoledronic acid treatment
    • Nguyen HV, Ingram KB, Beilin J. Profound hypocalcaemia after zoledronic acid treatment. Med J Aust 2005 182 : 494 5.
    • (2005) Med J Aust , vol.182 , pp. 494-5
    • Nguyen, H.V.1    Ingram, K.B.2    Beilin, J.3
  • 6
    • 17444404170 scopus 로고    scopus 로고
    • Zoledronic acid-induced severe hypocalcemia in a prostate cancer patient with extensive bone metastases
    • Patel K, Brahmbhatt V, Ramu V. Zoledronic acid-induced severe hypocalcemia in a prostate cancer patient with extensive bone metastases. Tenn Med 2005 98 : 83 5.
    • (2005) Tenn Med , vol.98 , pp. 83-5
    • Patel, K.1    Brahmbhatt, V.2    Ramu, V.3
  • 7
    • 10944269168 scopus 로고    scopus 로고
    • Symptomatic hypocalcemia after treatment with zoledronic acid in a patient with multiple myeloma
    • Singh D, Chair NS, Sekhon JS. Symptomatic hypocalcemia after treatment with zoledronic acid in a patient with multiple myeloma. Ann Oncol 2004 15 : 1848.
    • (2004) Ann Oncol , vol.15 , pp. 1848
    • Singh, D.1    Chair, N.S.2    Sekhon, J.S.3
  • 8
    • 2342465529 scopus 로고    scopus 로고
    • Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostrate cancer and vitamin D deficiency
    • Breen TL, Shane E. Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostrate cancer and vitamin D deficiency. J Clin Oncol 2004 22 : 1531 2.
    • (2004) J Clin Oncol , vol.22 , pp. 1531-2
    • Breen, T.L.1    Shane, E.2
  • 9
    • 1042279459 scopus 로고    scopus 로고
    • Severe hypocalcemia after being given intravenous bisphosphonate
    • Peter R, Mishra V, Fraser WD. Severe hypocalcemia after being given intravenous bisphosphonate. BMJ 2004 328 : 335 6.
    • (2004) BMJ , vol.328 , pp. 335-6
    • Peter, R.1    Mishra, V.2    Fraser, W.D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.